CClinicalTrials.gg
Not yet recruitingNCT06655948OPERATEUpdated Oct 24, 2024

Outcome-related Performance Evaluation Through Revision and Analysis of inTraoperative Events

An observational study in Laparoscopic Abdominal Surgery, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Not yet recruiting at 5 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-24.

Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
700
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this prospective, multicentric, observational, cohort study is to evaluate intraoperative adverse events (iAEs) through video-based assessment (VBA) across minimal invasive procedures performed in general surgery departments. The main questions it aims to answer are:

  • The prevalence, type, and severity of iAEs
  • Correlation between iAE and clinical outcomes
  • Correlation between iAE and surgical performance
  • Qualitative analysis of root cause analysis and mitigation strategies
Read the detailed description

The OPERATE study is a prospective, multicenter observational cohort study focused on evaluating the prevalence and impact of intraoperative adverse events (iAEs) during minimally invasive surgeries. The study aims to systematically collect and analyze surgical videos and clinical outcomes from multiple centers. By using advanced video-based assessment (VBA) tools, such as the Objective Clinical Human Reliability Analysis (OCHRA) and the Severity of Intraoperative Events and Rectification (SEVERE) index, the study will examine how surgical performance correlates with post-operative outcomes.

The study will initially focus on colorectal surgery, with the possibility of expanding to other types of minimally invasive procedures. Videos of the surgeries will be recorded, de-identified, and uploaded to a centralized platform for analysis. The study also seeks to identify root causes of iAEs and develop strategies to prevent them. Data collection will include not only video-based assessments but also patient demographic details, surgical history, and post-operative recovery data.

By understanding the frequency and nature of iAEs, this study aims to improve surgical safety, reduce complications, and ultimately enhance the quality of patient care in a broad range of general surgical procedures. The findings may contribute to developing new training protocols, artificial intelligence instruments to model errors and increase procedural safety, and guidelines to optimize surgical performance and patient outcomes.

02

Conditions studied

  • Laparoscopic Abdominal Surgery

Keywords

  • Intraoperative Adverse Events
  • Video-Based Assessment
  • Minimally Invasive Surgery
  • Surgical Performance
  • Patient Outcomes
03

In context

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is the lead sponsor of 920 studies on the registry; 529 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients meeting eligibility criteria and scheduled for elective minimally-invasive surgery in the general surgery departments of participating centers.

Inclusion criteria

  • Patients scheduled for elective minimally-invasive surgery in participating centers
  • Patients with no contraindication to anesthesia and laparoscopic procedures
  • Capable of providing informed consent

Exclusion criteria

Exclusion Criteria:

  • Surgery performed with palliative intent or under unplanned/emergency setting
  • Pregnant or breastfeeding patient
  • Patient under legal custody or guardianship
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
700 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Prevalence of intraoperative adverse events

    The prevalence of iAEs will be assessed using validated VBA tools including the Objective Clinical Human Reliability Analysis (OCHRA), the European Association for Endoscopic Surgery (EAES) classification, and the Severity of Intraoperative Events and Rectification (SEVERE) index.

    Time frame: Day of the surgical procedure (1 day)

Secondary outcomes

  1. Outcomes correlation

    Correlation between iAE and clinical outcomes, overall and per iAEs severity

    Time frame: From the day of the surgical procedure up to 5 years of follow up

  2. Severity

    Prevalence per severity of iAE

    Time frame: Day of the surgical procedure (1 day)

  3. Video-Based Assessment

    Correlation between iAE and surgical performance assessed through validated VBA tools

    Time frame: Day of the surgical procedure (1 day)

  4. Root causes

    Qualitative analysis of root cause analysis and mitigation strategies

    Time frame: Day of the surgical procedure (1 day)

07

Study locations

5 sites
  • IHU Strasbourg
    Strasbourg, 67000, France
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Milan, MI 20122, Italy
  • Ospedale Isola TIberina - Gemelli Isola
    Rome, RM 00186, Italy
  • Azienda Ospedaliero-Universitaria Sant'Andrea
    Rome, RM 00189, Italy
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Rome, RO 00168, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06655948
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Responsible party
Sponsor
First posted
Oct 24, 2024
Start date
Oct 2024 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Oct 2029 (estimated)
Last update
Oct 24, 2024

Study contacts

Sergio Alfieri, prof
Contact
sergio.alfieri@policlinicogemelli.it
+390630154477
Sergio Alfieri
principal investigator · Fondazione Policlinico Universitario A. Gemelli, IRCCS

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion